Literature DB >> 17524772

Tunneled scleral incision to prevent vitreal reflux after intravitreal injection.

Eduardo B Rodrigues1, Carsten H Meyer, Astor Grumann, Helio Shiroma, Jonathan S Aguni, Michel E Farah.   

Abstract

PURPOSE: To investigate the efficacy of tunneled scleral incision compared with standard straight scleral incision to prevent vitreal reflux after intravitreal (IVT) injection.
DESIGN: Prospective comparative controlled nonrandomized clinical study.
METHODS: Eighty-eight eyes undergoing IVT-injection were allocated into four groups to compare the vitreal reflux after injection of 0.1 ml of triamcinolone acetonide (TA) and Avastin using a tunneled vs straight injection technique. The amount of intraoperative drug reflux was estimated by measuring the width of the subconjunctival bleb.
RESULTS: The mean measured reflux of volume was statistically less with the tunneled scleral incision (1.13 mm standard deviation [SD] +/- 1.16 for TA; 1.13 mm SD +/- 1.39 for Avastin) than in eyes undergoing the straight scleral injection (3.00 mm SD +/- 1.77 for TA; 3.18 mm SD +/- 1.68 for Avastin) for both Avastin and TA IVT-injections groups (P < .001).
CONCLUSIONS: The tunneled scleral incision promotes statistically significant less vitreal reflux for IVT drug injection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17524772     DOI: 10.1016/j.ajo.2007.01.035

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Visual perceptions induced by intravitreous injections of therapeutic agents.

Authors:  S Charalampidou; J Nolan; G O Ormonde; S Beatty
Journal:  Eye (Lond)       Date:  2011-01-28       Impact factor: 3.775

2.  Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique.

Authors:  Kyu-Seop Kim; Donghyun Jee
Journal:  Jpn J Ophthalmol       Date:  2011-09-23       Impact factor: 2.447

3.  Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle.

Authors:  Katrin Lorenz; Isabella Zwiener; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-21       Impact factor: 3.117

4.  [Three-dimensional visualization of sclerotomies with ultrasound biomicroscopy. Comparison of 20 and 23 gauge incisions on the porcine eyeball].

Authors:  V Witte; E Berger; R Guthoff; O Stachs
Journal:  Ophthalmologe       Date:  2011-07       Impact factor: 1.059

Review 5.  [Intravitreal injection. Monitoring to avoid postoperative complications].

Authors:  C H Meyer; F Ziemssen; H Heimann
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

6.  Penetration force, geometry, and cutting profile of the novel and old Ozurdex needle: the MONO study.

Authors:  Carsten H Meyer; Zengping Liu; Christian K Brinkmann; Eduardo B Rodrigues; Thomas Bertelmann
Journal:  J Ocul Pharmacol Ther       Date:  2014-05-06       Impact factor: 2.671

7.  A novel method for the measurement of reflux from intravitreal injections: data from 20 porcine eyes.

Authors:  Frank L Brodie; Jason Ruggiero; Devon H Ghodasra; Kian Eftekhari; James Z Hui; Alexander J Brucker; Brian L VanderBeek
Journal:  Curr Eye Res       Date:  2013-11-20       Impact factor: 2.424

8.  Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application.

Authors:  Fabian Höhn; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-21       Impact factor: 3.117

9.  The effects of injection site on the reflux following intravitreal injections.

Authors:  Burak Turgut; Tamer Demir; Ulku Celiker
Journal:  J Clin Med Res       Date:  2009-12-28

10.  [Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application].

Authors:  C H Meyer; S Mennel; N Eter
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.